Literature DB >> 21782539

Exploring reasons for very poor glycaemic control in patients with Type 2 diabetes.

Hamida Khan1, Shawarna S Lasker, Tahseen A Chowdhury.   

Abstract

AIM: The aim was to determine prevalence and reasons for very poor glycaemic control (HbA1c≥10% [86 mmol/mol]) amongst people with Type 2 diabetes in an ethnically diverse urban population.
METHODS: Databases of three primary health centres were searched for patients with Type 2 diabetes ≥1 year, most recent HbA1c≥10% [86 mmol/mol]. Patients were invited to explore reasons for poor glycaemic control and develop an individualised management plan. Review of glycaemic control was undertaken at 6 months.
RESULTS: Of a total population of 28,677, 1261 had Type 2 diabetes (4.4%). 143 (11.3%) had last recorded HbA1c≥10% [86 mmol/mol]; 128 were reviewed (46.9% South Asian). People with poorer control had longer duration of diabetes and more South Asian ethnicity. Reasons for poor glycaemic control were: THERAPY: lack of titration of tablets (7.8%) or insulin (12.5%), poor concordance with medication (14.0%), insulin refusal (11.7%), side effects (16.4%); Engagement: poor concordance with lifestyle (26.5%), lack of knowledge of diabetes (14.0%), infrequent attendance at clinic (16.4%); Psychosocial/mental health: denial that diabetes was a problem (7.0%), mental health problem (9.4%), social issues (10.9%); Occupation: refusal of insulin due to occupation (1.6%); difficulty in attending reviews (5.5%). At six month review, 54.5% of patients had improved HbA1c≥1%.
CONCLUSIONS: Poor control affects 1 in 10 of our population. We have determined a number of factors which may explain most causes. Individualised management using care planning can significantly improve control.
Copyright © 2011 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21782539     DOI: 10.1016/j.pcd.2011.07.001

Source DB:  PubMed          Journal:  Prim Care Diabetes        ISSN: 1878-0210            Impact factor:   2.459


  25 in total

1.  Machine Learning to Identify Predictors of Glycemic Control in Type 2 Diabetes: An Analysis of Target HbA1c Reduction Using Empagliflozin/Linagliptin Data.

Authors:  Angelo Del Parigi; Wenbo Tang; Dacheng Liu; Christopher Lee; Richard Pratley
Journal:  Pharmaceut Med       Date:  2019-06

2.  What do persons with diabetes want from community pharmacies? A qualitative study.

Authors:  Gitte Reventlov Husted; Rikke Nørgaard Hansen; Mira El-Souri; Janne Kunchel Lorenzen; Peter Bindslev Iversen; Charlotte Verner Rossing
Journal:  Pharm Pract (Granada)       Date:  2022-06-17

3.  Challenges and Expectations of Diabetic Foot Care from the Patients' Point of Views.

Authors:  Maryam Aalaa; Neda Mehrdad; Shoaleh Bigdeli; Afsaneh Dehnad; Zohreh Sohrabi; Kamran Soltani Arabshahi
Journal:  J Diabetes Metab Disord       Date:  2021-08-03

4.  Impact of reinforcement of diabetes self-care on poorly controlled diabetes: a randomized controlled trial.

Authors:  Elizabeth A Beverly; Shane M Fitzgerald; Kelly M Brooks; Brittney A Hultgren; Om P Ganda; Medha Munshi; Katie Weinger
Journal:  Diabetes Educ       Date:  2013-05-02       Impact factor: 2.140

5.  Potential diabetes overtreatment and risk of adverse events among older adults in Ontario: a population-based study.

Authors:  Iliana C Lega; Michael A Campitelli; Peter C Austin; Yingbo Na; Afshan Zahedi; Freda Leung; Catherine Yu; Susan E Bronskill; Paula A Rochon; Lorraine L Lipscombe
Journal:  Diabetologia       Date:  2021-01-25       Impact factor: 10.122

6.  The Effect of the COVID-19 Pandemic on Glycemic Monitoring and Other Processes of Care for Type 2 Diabetes: Protocol for a Retrospective Cohort Study.

Authors:  Mekha Mathew; Jeremy van Vlymen; Bernardo Meza-Torres; William Hinton; Gayathri Delanerolle; Ivelina Yonova; Michael Feher; Xuejuan Fan; Harshana Liyanage; Mark Joy; Fabrizio Carinci; Simon de Lusignan
Journal:  JMIR Res Protoc       Date:  2022-04-22

7.  Adherence to the American Diabetes Association standards of care among patients with type 2 diabetes in primary care in Saudi Arabia.

Authors:  Turki J Al Harbi; Ayla M Tourkmani; Hesham I Al-Khashan; Adel M Mishriky; Hala Al Qahtani; Ahmed Bakhiet
Journal:  Saudi Med J       Date:  2015-02       Impact factor: 1.484

8.  Study on risk factors (predisposing factors) for poor diabetes control during Hajj (1436/2015) in people with diabetes.

Authors:  Gulshad Hasan; Hanan Moabber; Arwa Alyamani; Ahmed Sayeed; Faisal Altatar
Journal:  Pak J Med Sci       Date:  2016 Sep-Oct       Impact factor: 1.088

9.  Barriers to Diabetes Self-Management in a Subset of New Zealand Adults with Type 2 Diabetes and Poor Glycaemic Control.

Authors:  Lynne Chepulis; Brittany Morison; Shemana Cassim; Kimberley Norman; Rawiri Keenan; Ryan Paul; Ross Lawrenson
Journal:  J Diabetes Res       Date:  2021-05-27       Impact factor: 4.011

10.  Sodium Glucose Co-transporter Type 2 (SGLT2) Inhibitors: Targeting the Kidney to Improve Glycemic Control in Diabetes Mellitus.

Authors:  Harold Bays
Journal:  Diabetes Ther       Date:  2013-10-19       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.